Analysis of Platelet Function from Thromboelastography Examination in Patients with Single and Multiple Antiplatelet Therapy after Percutaneous Coronary Intervention at Dr. Saiful Anwar Malang

Sasmojo Widito, Dadang Hendrawan, Dedy Irawan


Each year, approximately 3 million people with coronary heart disease worldwide undergo percutaneous coronary intervention (PCI). Dual antiplatelet therapy (DAPT) with aspirin and P2Y12 inhibitors became the primary therapy for 6-12 months after PCI. DAPT can be continued > 12 months at a high risk of thrombosis. About 9-10% of patients with dual antiplatelet therapy still experience ischemia. The platelet function examination by thromboelastography (TEG). This research is an analytic observational study using a cross-sectional method. This study was conducted in Saiful Anwar General Hospital. Patients were divided into two groups: (1) on-single antiplatelet therapy; (2) on-dual antiplatelet therapy. The outcome measured result of the platelet function test was divided into standard, low platelet function, and platelet hypercoagulability. An analysis of the differences between single or multiple antiplatelet administration and the platelet function results was performed. There were 52 research subjects, each group of single and multiple antiplatelet therapies as many as 26 people, most of the subjects were male (82.6%) with a mean age of 57. The results of this study showed that there was no significant difference in the results of platelet function examinations between single and multiple antiplatelet therapies after 12 months of dual antiplatelet therapy


Platelet; Thromboelastography; Percutaneous Coronary Intervention; Heart disease.

Full Text:



Banerjee, S., Angiolillo, D. J., Boden, W. E., Murphy, J. G., Khalili, H., Hasan, A. A., Harrington, R. A., & Rao, S. V. (2017). Use of Antiplatelet Therapy/DAPT for Post-PCI Patients Undergoing Noncardiac Surgery. Journal of the American College of Cardiology, 69(14), 1861–1870.

Berg, J. M., Zwart, B., van ’t Hof, A. W. J., Liem, A., Waltenberger, J., de Winter, R. J., & Jukema, J. W. (2017). Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention or after acute coronary syndrome. Netherlands Heart Journal, 25(12), 655–663.

Bonello, L., Tantry, U. S., Marcucci, R., Blindt, R., Angiolillo, D. J., Becker, R., Bhatt, D. L., Cattaneo, M., Collet, J. P., Cuisset, T., Gachet, C., Montalescot, G., Jennings, L. K., Kereiakes, D., Sibbing, D., Trenk, D., Van Werkum, J. W., Paganelli, F., Price, M. J., … Gurbel, P. A. (2010). Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate. Journal of the American College of Cardiology, 56(12), 919–933.

Cammerer, U., Dietrich, W., Rampf, T., Braun, S. L., & Richter, J. A. (2003). The Predictive Value of Modified Computerized Thromboelastography and Platelet Function Analysis for Postoperative Blood Loss in Routine Cardiac Surgery. Anesthesia & Analgesia, 96(1), 51–57.

Fontana, P., Roffi, M., & Reny, J. L. (2020). Platelet Function Test Use for Patients with Coronary Artery Disease in the Early 2020s. Journal of clinical medicine, 9(1), 194.

Hidayati, F., Irawan, B., & Mumpuni, H. (2017). Aspirin and Clopidogrel Resistance in Coronary Artery Disease. ACI (Acta Cardiologia Indonesiana), 3(1), 33.

Kasotakis, G., Pipinos, I. I., & Lynch, T. G. (2009). Current evidence and clinical implications of aspirin resistance. Journal of vascular surgery, 50(6), 1500–1510.

Kikkert, W. J., & Damman, P. (2018). Optimal duration of dual antiplatelet therapy for coronary artery disease. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 26(6), 321–333.

Levine G. N., Bates, E. R., Bittl, J. A., Brindis, R. G., Fihn, S. D., Fleisher, L. A., Granger, C. B., Lange, R. A., Mack, M. J., Mauri, L., Mehran, R., Mukherjee, D., Newby, L. K., O'Gara, P. T., Sabatine, M. S., Smith, P. K., Smith, S. C. Jr. (2016). 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. Circulation, 134(10), e123-55. doi: 10.1161/CIR.0000000000000404. Epub 2016 Mar 29. Erratum in: Circulation, 134(10),e192-4. PMID: 27026020.

Li, Y., Chang, H., Ni, L., Xue, P., Li, C., Yuan, L., Cui, H., & Yu, C. (2019). Analysis of thrombelastogram-guided medication in patients with coronary heart disease after percutaneous coronary intervention. Experimental and Therapeutic Medicine, 3047–3052.

Neumann, F. -J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., Jüni, P., Kastrati, A., Koller, A., Kristensen, S. D., Niebauer, J., Richter, D. J., Seferović, P. M., Sibbing, D., Stefanini, G. G., … Henderson, R. (2018). 2018 ESC/EACTS Guidelines on myocardial revascularization. European Heart Journal, 40(2), 87–165.

Rilantono, L. I., Rahajoe, A. U., & Santoso, K. (2018). Penyakit kardiovaskular (PKV) : 5 rahasia (1st ed., V). Jakarta: Fakultas Kedokteran Universitas Indonesia.

Sastroasmoro, S. (2014). Dasar-dasar metodologi penelitian klinis (5th ed.). Bagian Ilmu Kesehatan Anak, Fakultas Kedokteran, Universitas Indonesia.

Swallow, R. A., Agarwala, R. A., Dawkins, K. D., & Curzen, N. P. (2006). Thromboelastography: potential bedside tool to assess the effects of antiplatelet therapy?. Platelets, 17(6), 385–392.

Valgimigli, M., Bueno, H., Byrne, R. A., Collet, J. P., Costa, F., Jeppsson, A., Jüni, P., Kastrati, A., Kolh, P., Mauri, L., Montalescot, G., Neumann, F. J., Petricevic, M., Roffi, M., Steg, P. G., Windecker, S., Zamorano, J. L., Levine, G. N., ESC Scientific Document Group, ESC Committee for Practice Guidelines (CPG), … ESC National Cardiac Societies (2018). 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). European heart journal, 39(3), 213–260.

Yeh, R. W., Secemsky, E. A., Kereiakes, D. J., Normand, S. L., Gershlick, A. H., Cohen, D. J., Spertus, J. A., Steg, P. G., Cutlip, D. E., Rinaldi, M. J., Camenzind, E., Wijns, W., Apruzzese, P. K., Song, Y., Massaro, J. M., Mauri, L., & DAPT Study Investigators (2016). Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention. JAMA, 315(16), 1735–1749.

Zhao, S. W., Wang, Y. P., Xu, L. D., & Gang, W. (2016). The application of thromboelastogram in detection of indexes of antiplatelet therapy for coronary heart disease. Journal of thoracic disease, 8(12), 3515–3520.



  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.